ArticleInvestigational new drugs2023

Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumors.

Shubham Pant et al.PubMed ↗Publisher ↗

No numbers read from the abstract.